
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
hamartin CRISPR Activation Plasmid (h) | sc-402444-ACT | 20 µg | $397.00 | |||
hamartin CRISPR Activation Plasmid (h2) | sc-402444-ACT-2 | 20 µg | $397.00 |
Human TSC1 encodes hamartin, a scaffold protein that forms a functional complex with TSC2 (tuberin) to act as a GTPase-activating regulator of RHEB and restrain mTORC1 signaling. Through this axis, hamartin integrates growth factor and energy-sensing inputs to control protein synthesis, autophagy, cell growth, and metabolic homeostasis. Disruption of TSC1-mediated control of mTORC1 perturbs cellular size and proliferation programs and alters stress responses. Genetic variation in TSC1 is linked to tuberous sclerosis complex–related biology and is widely studied in models of dysregulated mTOR pathway signaling.
hamartin CRISPR Activation Plasmid (h) provides a targeted, non-destructive approach to upregulating endogenous TSC1 expression without altering the underlying DNA sequence.
hamartin CRISPR Activation Plasmid (h) is a three-plasmid synergistic activation mediator (SAM) system engineered for highly efficient, site-specific transcriptional upregulation of the TSC1 locus in human cell lines. The system is built around a catalytically inactive Cas9 (dCas9) carrying two inactivating mutations (D10A and N863A) that eliminate nuclease activity while preserving DNA binding. This dCas9 is fused to VP64, a potent transcriptional activator, and is co-expressed with a blasticidin resistance gene for selection. The second plasmid encodes the MS2-p65-HSF1 fusion protein, a secondary activator complex that works in concert with dCas9-VP64, alongside a hygromycin resistance gene. The third plasmid encodes a target-specific 20 nt sgRNA fused to two MS2 RNA aptamers that recruit the MS2-p65-HSF1 complex to the activation site, accompanied by a puromycin resistance gene. The three plasmids are delivered at a 1:1:1 mass ratio for balanced expression of all system components.
Once assembled at the target locus, the SAM complex binds within approximately 200 bp upstream of the TSC1 transcriptional start site, where VP64, p65, and HSF1 act in concert to recruit transcriptional machinery and drive upregulation of endogenous hamartin expression. Unlike nuclease-active Cas9, dCas9 does not introduce double-strand breaks or modify the genomic sequence, preserving the native TSC1 locus and enabling the study of hamartin-dependent transcriptional responses at the endogenous locus, making it a valuable tool for functional studies, target gene identification, and the modeling of hamartin pathway restoration in tumor cells with silenced or reduced TSC1 expression.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.